06/07/07
Marketplace AM for June 7, 2007
Episode Description:
0
Bedouin women settle into worklife
Israel's Bedouins have been trying to transition from thousands of years of nomadic life to a more settled existence, a big challenge for a community with 60% unemployment. But women have found surprisingly equal footing, Shia Levitt reports.
0
Economics of a superstar
Jun 7, 2007
LeBron James has arrived. He's lived up to his promise in Cleveland and his spotlight may draw some free agents hungry for a championship, but it still won't be easy for the Cavs to build a legacy team around him, says David Carter.
0
Time to sell?
Brokerage firm Morgan Stanley has a sophisticated market model with three key indicators and they're all blinking SELL for the first time since the dot-com bust. But it's not time for panic, Ambrose Evans-Pritchard explains.
0
GPShopping is here
Sprint launches a new service today that uses global positioning technology to help shoppers find products in stores. And this is just the beginning, Ashley Milne-Tyte reports.
0
Holding the immigration bill together... or not
Jun 7, 2007
The Senate's fragile bipartisan compromise on immigration is being tested by a series of proposed amendments, but the push and shove could come to an end soon. A vote may be forced as early as today, Jeremy Hobson reports.
0
New tale of an old scandal
The cast: British defense giant BAE, American banks, a Saudi Arabian prince. The alleged plotline: Contractor pays prince hundreds of millions to secure $80 billion defense deal. Now word that U.S. banks may be involved. Stephen Beard tells us how.
0
We're charging up profits for MasterCard
For everything else, indeed. Shoppers are using plastic to pay more than ever and that's driving newly-public MasterCard stock way up. So what now? The company will probably invest in ways to make charging even easier, Jill Barshay reports.
0
Superbugs create super opportunity
You don't want to go to the hospital, the old joke goes, it's full of sick people! And, it turns out, increasingly you're likely to catch an antibiotic-resistant infection there. Scary for patients, but it could mean big bucks for big pharma. Helen Palmer reports.
0
Drug companies get what they pay for
Patients beware: The results of drug studies are heavily influenced by who footed the bill. And the industry probably won't change as long as there are researchers who need funding. Janet Babin reports.
Latest Stories
Browse the show calendar
Buzzworthy
Recent comments on our stories..
Three life rules from Donald Rumsfeld
Journalism: Practiced. Excellent interview. Thank you.
Annapolis57 | May 17, 2013
Three life rules from Donald Rumsfeld
Donald Rumsfeld's interview on Marketplace today was absolutely unbelievable. Really. Is one of his rules not to believe your own spin? I...
jgrothues | May 16, 2013
Three life rules from Donald Rumsfeld
Ryssdal's interview with Rumsfeld was breathtakingly inappropriate. "Marketplace?" If Ryssdal wants to promote his obvious biases...
rcd43 | May 16, 2013
How World Finance makes a killing lending on the installment (loan) plan
There is something fundamentally wrong with predatory lending businesses, whether they are pay day loans or installment contracts. The business...
entropyman | May 15, 2013
Connect
Submit your Personal Finance Questions to the Getting Personal blog.
BECOME A MARKETPLACE SOURCE!
Join the Public Insight Network and help us
tell the story.
Sign Up Now or browse recent questions from
the Network below.












